Identification of DOK genes as lung tumor suppressors

被引:104
作者
Berger, Alice H. [1 ,2 ,3 ,4 ,5 ]
Niki, Masaru [3 ,4 ,6 ]
Morotti, Alessandro [1 ,2 ,3 ,4 ]
Taylor, Barry S. [7 ]
Socci, Nicholas D.
Viale, Agnes [8 ]
Brennan, Cameron [9 ,10 ]
Szoke, Janos [4 ]
Motoi, Noriko [4 ]
Rothman, Paul B. [6 ]
Teruya-Feldstein, Julie [4 ]
Gerald, William L. [4 ,10 ]
Ladanyi, Marc [4 ,10 ]
Pandolfi, Pier Paolo [1 ,2 ,3 ,4 ,5 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Dept Med, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA
[2] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med,Dept Pathol, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02215 USA
[3] Sloan Kettering Inst, Canc Biol & Genet Program, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA
[5] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA
[6] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA
[7] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA
[8] Sloan Kettering Inst, Genom Core Lab, New York, NY USA
[9] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA
[10] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
关键词
BRONCHIOALVEOLAR STEM-CELLS; ACTIVATED PROTEIN-KINASE; NEGATIVE REGULATORS; DOCKING PROTEIN; MAP KINASE; CANCER; CARCINOMA; LEUKEMIA; RECEPTOR; FAMILY;
D O I
10.1038/ng.527
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genome-wide analyses of human lung adenocarcinoma have identified regions of consistent copy-number gain or loss, but in many cases the oncogenes and tumor suppressors presumed to reside in these loci remain to be determined. Here we identify the downstream of tyrosine kinase (Dok) family members Dok1, Dok2 and Dok3 as lung tumor suppressors. Single, double or triple compound loss of these genes in mice results in lung cancer, with penetrance and latency dependent on the number of lost Dok alleles. Cancer development is preceded by an aberrant expansion and signaling profile of alveolar type II cells and bronchioalveolar stem cells. In human lung adenocarcinoma, we identify DOK2 as a target of copy-number loss and mRNA downregulation and find that DOK2 suppresses lung cancer cell proliferation in vitro and in vivo. Given the genomic localization of DOK2, we propose it as an 8p21.3 haploinsufficient human lung tumor suppressor.
引用
收藏
页码:216 / U27
页数:10
相关论文
共 41 条
  • [1] Self-renewal and solid tumor stem cells
    Al-Hajj, M
    Clarke, MF
    [J]. ONCOGENE, 2004, 23 (43) : 7274 - 7282
  • [2] p62(dok): A constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells
    Carpino, N
    Wisniewski, D
    Strife, A
    Marshak, D
    Kobayashi, R
    Stillman, B
    Clarkson, B
    [J]. CELL, 1997, 88 (02) : 197 - 204
  • [3] An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors
    Chitale, D.
    Gong, Y.
    Taylor, B. S.
    Broderick, S.
    Brennan, C.
    Somwar, R.
    Golas, B.
    Wang, L.
    Motoi, N.
    Szoke, J.
    Reinersman, J. M.
    Major, J.
    Sander, C.
    Seshan, V. E.
    Zakowski, M. F.
    Rusch, V.
    Pao, W.
    Gerald, W.
    Ladanyi, M.
    [J]. ONCOGENE, 2009, 28 (31) : 2773 - 2783
  • [4] Cong F, 1999, MOL CELL BIOL, V19, P8314
  • [5] Dok-6, a novel p62 Dok family member, promotes Ret-mediated neurite outgrowth
    Crowder, RJ
    Enomoto, H
    Yang, M
    Johnson, EM
    Milbrandt, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) : 42072 - 42081
  • [6] Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins
    Di Cristofano, A
    Carpino, N
    Dunant, N
    Friedland, G
    Kobayashi, R
    Strife, A
    Wisniewski, D
    Clarkson, B
    Pandolfi, PP
    Resh, MD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) : 4827 - 4830
  • [7] p62dok, a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210bcr-abl
    Di Cristofano, A
    Niki, M
    Zhao, MM
    Karnell, FG
    Clarkson, B
    Pear, WS
    Van Aelst, L
    Pandolfi, PP
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) : 275 - 284
  • [8] Biology of normal and acute myeloid leukemia stem cells
    Dick, JE
    Lapidot, T
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (05) : 389 - 396
  • [9] Dobbin KK, 2005, CLIN CANCER RES, V11, P565
  • [10] EMI M, 1992, CANCER RES, V52, P5368